Table 3

Number of asthma patients receiving different types of asthma medication before the new oral β-blocker (n=599)

MedicationNo. of patients receiving medications (%)
SABA376 (62.8)
LABA44 (7.3)
ICS274 (45.7)
LABA/ICS70 (11.7)
LKT18 (3.0)
THEO4 (0.7)

  • ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; LKT, leukotriene antagonist; SABA, short-acting β2-agonist; THEO, theophylline.